ETEX Corporation Announces Distribution Agreement with Alph... (arkets its spine products in Europe. In ...)

(Date:11/27/2009)...ng unprecedented medical, economic burdens, study ...News) -- The number of people with diabetes in the... 25 years, a new study predicts. , That would b...e with the disease, up from 23.7 million today. ,...with diabetes will triple, the study also warns, r...

(Date:11/27/2009)... Multi-purpose bilingual coloring books desig... the business community to educate - inform parent... Safety issues to Dinosuars to ABC,S and a host of...uis, MO (PRWEB) November 27, 2009 -- Today’s... to keep them busy any hour of the day, but one of...

(Date:11/26/2009)..., Nov. 27 With cold and flu season...good practices to control the spread of infections... not only to keep ourselves healthy, but to avoid ...inerty, RN, MS, CIC (certified in infection-contro...upational health at Hospital for Special Surgery (...

(Date:11/26/2009)...ering drug tetrathiomolybdate (TM) has been shown ...son disease, a disease caused by an overload of co... known. Very little, however, is known about how t...udy led by Northwestern University researchers now...ional structure of TM bound to copper-loaded metal...

(Date:11/26/2009)... No more letters from the North Pole, Textsan...messages from Santa , Nor...erational efficiencies at the North Pole Santa Cla...ren all over the globe informed of his Christmas p...o;s research department have identified a large an...

Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2 Health News:Diabetes Cases Expected to Double in 25 Years 3 Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4 Health News:Research sheds light on workings of anti-cancer drug 2 Health News:Research sheds light on workings of anti-cancer drug 3 Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2

[0] Diabetes Cases Expected to Double in 25 Years [1] Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books [1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use [1] Research sheds light on workings of anti-cancer drug [1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes

...eutical Companies, Inc. (NYSE: PRX ) today announ...armaceuticals, Inc. (Nasdaq: SPPI ) for $20,milli...he generic versions,of GlaxoSmithKline,s Imitrex(R...t, Par,s profit share will increase,from 38% to 95...

...Give the M.D. Degree Outside of the ...ll Cornell Medical College announced,today that it...Qatar,(WCMC-Q), part of Cornell University and the...tudents - 9 women and 6 men - represents,seven dif...

...tely held,manufacturer of innovative spinal implan...eived FDA 510(k) clearance to market their new Iso...tem is an extension of the,original Isobar Dynamic...ments in skeletally mature patients as an,adjunct ...

...rease Operating Cash Flows Inc...ration (NYSE: HLS ) (the "Company") today reporte...ended March 31, 2008. Compared to the,first quarte...rst quarter indicate our growth strategies are,gai...

...vestors Today at 5:30 p.m. EDT, FRAZER, Pa., May ...hat a Joint Advisory Committee to the U.S. Food an... approval of an expanded,label for FENTORA(R) (fen...erns about minimizing risks potentially associated...

...attend TCT2008 (Transcatheter Cardiovascular Thera...ardiovascular Research Foundation. TCT gathers lea...d the world to present and discuss developments in...o interventional cardiologists around the world. ,...

Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008 Scient'x Announces FDA 510(K) Clearance for Isobar DUO(TM) Dynamic Stabilization System HealthSouth Reports Results for First Quarter Ended March 31, 2008 Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA Media registration now open for TCT2008

(Date:11/24/2009)...,Nov.24/PRNewswire/-- ,, WHAT:RomHoubens,aBelgi...utoaccident,wasactuallyfullyconsciousandawakedurin...ent.TheDynaVoxEyeMaxwasfeaturedinthesegmenttoillus...onscanunlockcommunication. ,, WHEN:GoodMorningA...ww.dynavoxtech.com ,, WHO:RomHoubenswasanen...

(Date:11/24/2009)...J.,Nov.24/PRNewswire-FirstCall/--QuestDiagnosticsI...fdiagnostictesting,informationandservices,announce...ayHealthcareConferenceinNewYorkCity.Thepresentatio...asternTime. ,, Duringtheconference,thecompanywi...mate3%,operatingincometoexceed18%ofrevenues,anddil...

(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--AnadysPharmaceuticals...tatthe21stAnnualPiperJaffrayHealthcareConferenceon...heconferenceisbeingheldatTheNewYorkPalaceHotel.Ste...fAnadys,willprovideanoverviewofAnadysanditsclinica...poratepresentationwillbesimultaneouslywebcastandca...

Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2 Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2 Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2 Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 1 Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 2 Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 3 Wolves lose their predatory edge in mid life new U of Minnesota study shows 60083 1 Wolves lose their predatory edge in mid life new U of Minnesota study shows 60083 2 NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 1 NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 2 NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 3 NCI awards 2415 2 million to create Princeton Physical Sciences Oncology Center 10525 4

[0] DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years [0] Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference [0] Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference

...d Among Patients with,Active Disease, MOUNTAIN VIE...yx, Inc., a clinical-stage biopharmaceutical compa...alizing,orally-administered therapeutics that targ... the company,s Phase 2 clinical trial of,Traficet-...agent,that targets the chemokine receptor CCR9. Cl...

...th Monoclonal Antibody,Targeting Interleukin-9 (IL...r IL-9 Inhibition in Developing Potential Asthma,T...ire-FirstCall/ --,MedImmune, Inc. today announced ...ess within the company,s inflammatory,disease pipe...studies with its monoclonal antibody (MAb) targeti...

Other Medicine Technology:ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 2 ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 3 ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 4 ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 5 MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2 MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3 MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4 MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5 MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6 MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7

ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations

Softtouch

Patil Stereotactic System

CT Micro Stereotactic System

Cygnus-PFS() Image-Guided Surgery System

Medicine Products:

Softtouch Patil Stereotactic System CT Micro Stereotactic System Cygnus-PFS() Image-Guided Surgery System

ETEX Corporation Announces Distribution Agreement with Alph...(arkets its spine products in Europe. In ...),Health